MedPath

Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction

Not Applicable
Conditions
Portal Hypertension
Liver Cirrhosis
Interventions
Drug: low molecular weight heparin
Registration Number
NCT03171727
Lead Sponsor
West China Hospital
Brief Summary

Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction is defined as a loss of decompression of the portal venous system due to occlusion or stenosis of the TIPS. Occlusion of the TIPS can either be due to thrombosis or hyperplasia of the intima. Thrombosis of the TIPS usually occurs early and can happen within 24 hours of TIPS creation. The frequency of this complication is on the order of 10%-15% when bare stents are used. Post-TIPS short-term low molecular weight heparin (LMWH) was used to prevent the early thrombosis formation. Weather post-TIPS LMWH was necessary when polytetrafluoroethylene-covered stent was used during TIPS creation was not answered. The present study was designed to evaluate the effect of short-term use of LMWH on early TIPS dysfunction.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
117
Inclusion Criteria
  1. Diagnosis of liver cirrhosis
  2. Technical success of TIPS was achieved.
Exclusion Criteria
  1. Non-cirrhotic portal hypertension
  2. Portal vein thrombosis
  3. Budd-Chiari syndrome
  4. Pregnancy
  5. Contradictions to anticoagulation therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
study grouplow molecular weight heparinAfter TIPS procedure was performed, low molecular weight heparin was given for three days.
Primary Outcome Measures
NameTimeMethod
TIPS patency rateone year

Analysis

Secondary Outcome Measures
NameTimeMethod
Mortality rateone year

Analysis

LMWH-related complicationone month

Analysis

Trial Locations

Locations (1)

West china Hospital

🇨🇳

Chengdu, China

© Copyright 2025. All Rights Reserved by MedPath